ChartRow logo
AMLX
$28.77+5.27%
as of close, Oct 20, 2026
☾ AH $28.77 +5.27%
PeersMRNALLYMDTUNHJNJTMO
Share this page

Amylyx Pharmaceuticals Inc. trailing returns

How Amylyx Pharmaceuticals Inc. (AMLX) has performed over the last day, week, month and year and since inception, through October 20, 2026 — price return and dividends side by side, with the worst drop inside each window.

Trailing returns by period#

To 2026-10-20. Price return + dividends = total return. Per year (CAGR) for windows of a year or more, with the cumulative total return beneath. Worst drop: the deepest fall in the price from a high inside the window, and when it bottomed.

PeriodPriceDivsTotalWorst drop
1 day+5.3%+0.0%+5.3%—
5 days+7.2%+0.0%+7.2%-4.7%Oct 16
1 month-11.2%+0.0%-11.2%-20.2%Oct 16
YTD+138.2%+0.0%+138.2%-33.6%Oct 16
1 year+87.2%+0.0%+87.2%-33.6%Oct 2026
Since inception (2022)+10.2%+0.0%+10.2%+59.2%-96.0%Jun 2024

Growth of AMLX#

Actual level with dividends reinvested (solid); dashed lines are each window's constant-rate path from start to today.

  • Since inception (2022)+10.2%/year · +59.2%

Methodology#

Trailing returns measure from the closest close about N years before the latest close (2026-10-20). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Price return is the change in AMLX's closing price; total return reinvests dividends (from its split- and dividend-adjusted closes); the dividends column is the difference between the two. The worst drop is the largest fall in the closing price from a high to a later low inside the window, the way a drawdown is usually quoted. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.

FAQ#

What is Amylyx Pharmaceuticals Inc.'s return since inception?
Since 2022, Amylyx Pharmaceuticals Inc. (AMLX) has compounded at about +10.2% a year — +59.2% in total.

More on Amylyx Pharmaceuticals Inc.